FDA CBER Postmarket Safety & Surveillance

FDA CBER Postmarket Safety & Surveillance

Food and Drug Administration (FDA) [HHS]

This investment provides the ability to monitor adverse events, safety signals, and product quality indications; identify potential products adulteration or other defects; implement Postmarket regulatory actions; and disseminate safety information to the public. This ability ensures safe products post approval and effective communication of safety events.

Non-major IT Investments

None